Growth Clinical Trial
Official title:
Do Infants Fed With BabyNes™ System Grow in Agreement With the World Health Organization (WHO) Reference?
Our main research question is: Do infants fed with BabyNes Nutrition System grow in agreement
with the WHO reference?
Our second question is: Do infants fed with BabyNes Nutrition System have a metabolic profile
closer to breastfed infants?
In order to answer both questions an observational trial will be carried out for 12 months in
order to measure weight and to calculate the weight for age z-scores according to the WHO
reference.
A breastfeeding group will be used as reference for the metabolic parameters measured in
blood of infants from Chinese background.
The effect of the Babynes formulas will be compared to the metabolic values obtained from
this breast-feeding reference group.
Design:
12 months-study, with a breastfeeding group for the comparison of metabolic values obtained
from a Chinese Reference population.
Number of subjects:
In total, 120 subjects shall be enrolled. 80 subjects will be assigned in formula fed group
and 40 subjects to breast feeding group. 20% dropouts are already considered for the sample
size of 120.
Product(s) to be tested:
For formula fed group:
- BabyNes 1 months: 0-1 month of age
- BabyNes 2 months: 1-2 months of age
- BabyNes 3-6 months: 3-6 months of age
- BabyNes 7-12 months: 7-12 months of age
For breast feeding group:
- Nan HA 1 once the mothers are no more breastfed from 4 months until 6 months old.
- Nan HA 2 once the mothers are no more breastfed from 6 months until 1 year old.
Amount, dosage, route of administration, duration of study product:
Subjects are included in the study for duration of upto 1 year old of the infant.
For FF group:
From birth to 4 months, they are exclusively fed with the infant formula dispenser (ad
libitum).
From 4 months of age they can start diversification but they maintain the adapted infant
formula to the age until 12 months.
For BF group:
Mothers are encouraged to exclusively breast feed the infant up to 6 months old or at least
until 4 months old. From 4 months of age, or later than 4 months with no more breastfeeding,
they can start Nan HA1 / HA 2 (commercial formula) until the age of 12 months. The amount
should be suitable for the age and appetite of the infants.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05551975 -
Preterm Infants Fed a Human Milk Fortifier
|
N/A | |
Completed |
NCT01721512 -
The Growth and Development of Breast and Formula Fed Term Asian Infants
|
N/A | |
Completed |
NCT01162798 -
Preterm Infant Growth
|
N/A | |
Active, not recruiting |
NCT00970398 -
Effect of an Infant Formula on Infant Growth, Health and Immune Functions
|
N/A | |
Completed |
NCT01666457 -
Impact of Implementing an Infant Driven Feeding Program on Oral Feeding and Growth Outcomes of Medically Fragile Infants in the Neonatal ICU (NICU)
|
||
Completed |
NCT00808756 -
Study on Fermentable Carbohydrates in Healthy Infants
|
N/A | |
Completed |
NCT00997971 -
Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein
|
Phase 3 | |
Completed |
NCT03276663 -
Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula
|
N/A | |
Recruiting |
NCT02695784 -
Probiotics After Discharge
|
Phase 4 | |
Withdrawn |
NCT02860026 -
Growth and Tolerance of Healthy Term Infants Fed Cow's Milk-Based Infant Formulas
|
N/A | |
Completed |
NCT01128517 -
Maternal Education on Complementary Feeding and Infant Outcome
|
N/A | |
Completed |
NCT00282113 -
Effects of Probiotic and Prebiotic Combinations on Premature Infants
|
N/A | |
Completed |
NCT03276884 -
Growth and Tolerance of Young Infants
|
N/A | |
Completed |
NCT04055363 -
Human Milk Oligosaccharides (HMOs) Post-market Study on Infants
|
N/A | |
Completed |
NCT05302427 -
Infant Massage and Infant Growth, Mother-Infant Attachment, and Maternal Self-Confidence
|
N/A | |
Not yet recruiting |
NCT05616117 -
Next-generation Effects of Vitamin D Supplementation in Pregnancy
|
||
Active, not recruiting |
NCT02410057 -
Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula
|
N/A | |
Completed |
NCT01109849 -
Novel Approach to Stimulant Induced Weight Suppression and Its Impact on Growth
|
Phase 4 | |
Completed |
NCT01158352 -
Study to Evaluate the Effect of Short Treatment With Nutritional Supplementation Standardized Innovative Formula, on Growth and Weight Gain in Short and Lean Prepubertal Children
|
N/A | |
Completed |
NCT01210391 -
Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
|
N/A |